Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipients
NCT04263597
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Hematopoietic Stem Cell Transplant
Interventions
DRUG:
2'-fucosyllactose
Sponsor
Children's Hospital Medical Center, Cincinnati